Title: Anavex Life Sciences Corp. (AVXL) 10K Annual Reports & 10Q SEC Filings
URL: https://last10k.com/sec-filings/avxl

HOME


LOGIN


PREMIUM


FREE TRIAL


SEC FILINGS


STOCK SCREENERS


EARNINGS


TRENDING


STOCKTWITS


INSIDER TRADING


SENTIMENT ANALYSIS


MANAGER PORTFOLIOS


LATE CORPORATE NEWS






				 



Anavex Life Sciences Corp. (AVXL) SEC Filing 10-K Annual Report for the fiscal year ending Saturday, September 30, 2023


Home
SEC Filings
Anavex Life Sciences Corp. (AVXL)
10-K Annual Report Mon Nov 27 2023






SEC Filings



 
AVXL Valuations





Intrinsic Value





Financial Stability





Financial Ratios





Insider Trades





Manager Portfolios





Notifications





 
AVXL Annual Reports
				  





10-K Annual Report November 2023


PDF

PDF


Select PDF Feature:
Include Exhibits
Highlight YoY Changes

10-K Only


Word
Excel
CSV








									10-K Annual Report November 2022																






									10-K Annual Report November 2021																






									10-K Annual Report December 2020																






									10-K Annual Report December 2019																






									10-K Annual Report December 2018																






									10-K Annual Report December 2017																






									10-K Annual Report December 2016																






									10-K Annual Report December 2015																






AVXL Quarterly Reports
				  





									10-Q Quarterly Report August 2024																






									10-Q Quarterly Report May 2024																






									10-Q Quarterly Report February 2024																






									10-Q Quarterly Report August 2023																






									10-Q Quarterly Report May 2023																






									10-Q Quarterly Report February 2023																






									10-Q Quarterly Report August 2022																






									10-Q Quarterly Report May 2022																






									10-Q Quarterly Report February 2022																






									10-Q Quarterly Report August 2021																






AVXL Corporate News
				  





									Ending Agreement																	July 2024







									Vote of Security Holders																	June 2024







									Earnings ReleaseFinancial Exhibit																	May 2024







									Vote of Security Holders																	May 2023







									Bylaw ChangeFinancial Exhibit																	April 2023







									Regulated Disclosure																	March 2023







									Financial ExhibitOther Events																	February 2023







									Financial ExhibitOther Events																	December 2022







									Vote of Security Holders																	May 2022







									Event for OfficersFinancial Exhibit																	April 2022













Last10K.com | 10-K Annual Report Mon Nov 27 2023






Anavex Life Sciences Corp.


													CIK: 1314052
																										Ticker: AVXL




10-K Annual Report Summary
 10-K Annual Report
 10-K YoY Changes
 Annual Proxy




Anavex Life Sciences Corp.

HISTORY
TOOLS


CIK: 1314052
Ticker: AVXL




Cover - USD ($) $ in Millions12 Months EndedSep. 30, 2023Nov. 24, 2023Mar. 31, 2023Cover [Abstract]   Document Type10-K  Amendment Flagfalse  Document Annual Reporttrue  Document Transition Reportfalse  Document Period End DateSep. 30,  2023  Document Fiscal Period FocusFY  Document Fiscal Year Focus2023  Current Fiscal Year End Date--09-30  Entity File Number001-37606  Entity Registrant NameANAVEX LIFE SCIENCES CORP.  Entity Central Index Key0001314052  Entity Tax Identification Number98-0608404  Entity Incorporation, State or Country CodeNV  Entity Address, Address Line One630 5th Avenue  Entity Address, Address Line Two20th Floor  Entity Address, City or TownNew York  Entity Address, State or ProvinceNY  Entity Address, CountryUS  Entity Address, Postal Zip Code10111  City Area Code844  Local Phone Number689-3939  Title of 12(b) SecurityCommon    Stock, $0.001 par value  Trading SymbolAVXL  Security Exchange NameNASDAQ  Entity Well-known Seasoned IssuerYes  Entity Voluntary FilersNo  Entity Current Reporting StatusYes  Entity Interactive Data CurrentYes  Entity Filer CategoryLarge Accelerated Filer  Entity Small Businessfalse  Entity Emerging Growth Companyfalse  Entity Shell Companyfalse  Entity Public Float  $ 667Entity Common Stock, Shares Outstanding 82,086,511 ICFR Auditor Attestation Flagtrue  Document Financial Statement Error Correction [Flag]false  Auditor NameGRANT THORNTON LLP  Auditor LocationMelville, New York  Auditor Firm ID248  

 

Please wait while we load the requested 10-K report or click the link below:https://last10k.com/sec-filings/report/1314052/000173112223002197/e5240_10k.htm


View differences made from one year to another to evaluate Anavex Life Sciences Corp.'s financial trajectory





Sample 10-K Year-over-Year (YoY) Comparison



Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Anavex Life Sciences Corp..

Continue







Assess how Anavex Life Sciences Corp.'s management team is paid from their Annual Proxy





Screenshot example of actual Proxy Statement




Anavex Life Sciences Corp.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

Voting Procedures
Board Members
Executive Team
Salaries, Bonuses, Perks
Peers / Competitors


Continue














SEC Filing Tools




 Sections
 Exhibits
 Stats


 
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report





Cover





Consolidated Balance Sheets





Consolidated Balance Sheets (Parenthetical)





Consolidated Statements Of Cash Flows





Consolidated Statements Of Changes In Stockholders' Equity





Consolidated Statements Of Operations And Comprehensive Loss





Consolidated Statements Of Operations And Comprehensive Loss (Parenthetical)





Accrued Liabilities





Accrued Liabilities (Details)





Accrued Liabilities (Tables)





Business Description And Basis Of Presentation





Commitments And Contingencies





Commitments And Contingencies (Details 1)





Commitments And Contingencies (Details 2)





Commitments And Contingencies (Details 3)





Commitments And Contingencies (Details 4)





Commitments And Contingencies (Details 5)





Commitments And Contingencies (Details 6)





Commitments And Contingencies (Details Narrative)





Commitments And Contingencies (Details)





Commitments And Contingencies (Tables)





Equity Offerings





Equity Offerings (Details Narrative)





Income Taxes





Income Taxes (Details 1)





Income Taxes (Details 2)





Income Taxes (Details Narrative)





Income Taxes (Details)





Income Taxes (Tables)





Other Income





Other Income (Details Narrative)





Subsequent Events





Summary Of Significant Accounting Policies





Summary Of Significant Accounting Policies (Details Narrative)





Summary Of Significant Accounting Policies (Policies)




 
Material Contracts, Statements, Certifications & more
Anavex Life Sciences Corp. provided additional information to their SEC Filing as exhibits





Exhibit 14.1: Code Of Ethics





Exhibit 21.1: Subsidaries Of The Registrant





Exhibit 23.1: Consents Of Experts And Counsel





Exhibit 23.2: Consents Of Experts And Counsel





Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification





Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification





Exhibit 32.1: Section 1350 Certification





Exhibit 97.1: Exhibit 97.1






Ticker: AVXL CIK: 1314052
Form Type: 10-K Annual Report
Accession Number: 0001731122-23-002197
Submitted to the SEC: Mon Nov 27 2023 4:30:41 PM EST
Accepted by the SEC: Mon Nov 27 2023
Period:  Saturday, September 30, 2023
Industry: Commercial Physical And Biological Research						
External Resources:
 Stock Quote
 Social Media
 SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/avxl/0001731122-23-002197.htm








About 
											Contact 
											Help 
											API 
											Privacy 
											Terms 
									


© 2012 - 2024 Last10K.com All Rights Reserved









×
You're Signed Out
Sign in for the full experience


Sign in
Join Now








Intrinsic Value Calculator








Screenshot of intrinsic value for AT&T (2019)




Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not
Continue












Never Miss A New SEC Filing Again








Screenshot taken from Gmail for a new 10-K Annual Report




Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news
Continue












We Highlighted This SEC Filing For You








Screenshot taken from Wynn's 2018 10-K Annual Report




Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q
Continue












Widen Your SEC Filing Reading Experience








Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report




Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view
Continue












Uncover Actionable Information Inside SEC Filings








Screenshot taken from Lumber Liquidators 10-K Annual Report




Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q
Continue












Adobe PDF, Microsoft Word, Excel and CSV Downloads








Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats




Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe Acrobat (PDF), Microsoft Word (DOCX), Excel (XLSX) and Comma-Delimited (CSV) files for offline viewing, annotations and analysis
Continue












Adobe PDF, Microsoft Word, Excel and CSV Downloads








Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats




Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe Acrobat (PDF), Microsoft Word (DOCX), Excel (XLSX) and Comma-Delimited (CSV) files for offline viewing, annotations and analysis
Continue












Financial Stability Report








Screenshot of financial stability report for Coco-Cola (2019)




Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity
Continue












Get a Better Picture of a Company's Performance








Available Financial Ratios




Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years
Continue












See when company executives buy or sell their own stock








Screenshot taken from Euronet (EEFT)




Last10K.com Member Feature

Use our calculated cost dollar values to discover when and how much registered owners BUY, SELL or excercise their company stock OPTIONS aggregated from Form 4 Insider Transactions SEC Filings
Continue












See how institutional managers trade a stock








Screenshot taken from General Motors (GM)




Last10K.com Member Feature

View which hedge funds, pension / retirement funds, endowments, banks and insurance companies have increased or decreased their positions in a particular stock. Includes Ownership Percent, Buy versus Sell comparison, Put-Call ratio and more
Continue












FREE Financial Statements








Screenshot of actual balance sheet from company 10-K Annual Report




Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports
Continue for FREE












SEC Filing Exhibit
 PDF Download



Loading SEC Filing Exhibit...








SEC Filing Financial Summary
 PDF Download
 Excel Download



Loading SEC Filing Financial Summary...

